CLINICAL CHARACTERISTICS AND PREDICTORS OF MORTALITY DIFFER BETWEEN PULMONARY AND ABDOMINAL SEPSIS

ABSTRACT Background: Pulmonary sepsis and abdominal sepsis have pathophysiologically distinct phenotypes. This study aimed to compare their clinical characteristics and predictors of mortality. Methods: In this multicenter retrospective trial, 1,359 adult patients who fulfilled the Sepsis-3 criteria were enrolled and classified into the pulmonary sepsis or abdominal sepsis groups. Plasma presepsin was measured, and the scores of Acute Physiology and Chronic Health Evaluation (APACHE) II, Mortality in Emergency Department Sepsis (MEDS), and Simplified Acute Physiology Score (SAPS) II were calculated at enrollment. Data on 28-day mortality were collected for all patients. Results: Compared with patients with abdominal sepsis (n = 464), patients with pulmonary sepsis (n = 895) had higher 28-day mortality rate, illness severity scores, incidence of shock and acute kidney injury, and hospitalization costs. Lactate level and APACHE II and MEDS scores were independently associated with 28-day mortality in both sepsis types. Independent predictors of 28-day mortality included Pao2/Fio2 ratio (hazard ratio [HR], 0.998; P < 0.001) and acute kidney injury (HR, 1.312; P = 0.039) in pulmonary sepsis, and SAPS II (HR, 1.037; P = 0.017) in abdominal sepsis. A model that combined APACHE II score, lactate, and MEDS score or SAPS II score had the best area under the receiver operating characteristic curve in predicting mortality in patients with pulmonary sepsis or abdominal sepsis, respectively. Interaction term analysis confirmed the association between 28-day mortality and lactate, APACHE II score, MEDS score, SAPS II score, and shock according to the sepsis subgroups. The mortality of patients with pulmonary sepsis was higher than that of patients with abdominal sepsis among patients without shock (32.9% vs. 8.8%; P < 0.001) but not among patients with shock (63.7 vs. 48.4%; P = 0.118). Conclusions: Patients with pulmonary sepsis had higher 28-day mortality than patients with abdominal sepsis. The study identified sepsis subgroup-specific mortality predictors. Shock had a larger effect on mortality in patients with abdominal sepsis than in those with pulmonary sepsis.

[1]  Su Hwan Lee,et al.  Clinical outcomes and prognostic factors of patients with sepsis caused by intra-abdominal infection in the intensive care unit: a post-hoc analysis of a prospective cohort study in Korea , 2022, BMC infectious diseases.

[2]  M. Churpek,et al.  Development and validation of novel sepsis subphenotypes using trajectories of vital signs , 2022, Intensive Care Medicine.

[3]  Jun Lyu,et al.  Risk factor analysis and nomogram for predicting in-hospital mortality in ICU patients with sepsis and lung infection , 2022, BMC Pulmonary Medicine.

[4]  T. van der Poll,et al.  Source-specific host response and outcomes in critically ill patients with sepsis: a prospective cohort study , 2021, Intensive Care Medicine.

[5]  C. Sprung,et al.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 , 2021, Intensive Care Medicine.

[6]  Hongli Xiao,et al.  Potential Value of Presepsin Guidance in Shortening Antibiotic Therapy in Septic Patients: a Multicenter, Prospective Cohort Trial , 2021, Shock.

[7]  B. Zhu,et al.  Prognosis and Risk Factors of Sepsis Patients in Chinese ICUs: A Retrospective Analysis of a Cohort Database , 2021, Shock.

[8]  Niranjan Kissoon,et al.  Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study , 2020, The Lancet.

[9]  A. Lassen,et al.  Prevalence of organ failure and mortality among patients in the emergency department: a population-based cohort study , 2019, BMJ Open.

[10]  J. Timsit,et al.  Clinical controversies in abdominal sepsis. Insights for critical care settings. , 2019, Journal of critical care.

[11]  J. Villar,et al.  Epidemiology and Changes in Mortality of Sepsis After the Implementation of Surviving Sepsis Campaign Guidelines , 2019, Journal of intensive care medicine.

[12]  Jeremy C. Weiss,et al.  Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. , 2019, JAMA.

[13]  H. Okudera,et al.  Variations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in Japan , 2019, Journal of Intensive Care.

[14]  C. Garciarena,et al.  Inhibition of Vascular Endothelial Cell Leak Following Escherichia coli Attachment in an Experimental Model of Sepsis , 2018, Critical care medicine.

[15]  T. West,et al.  Utility of SOFA score, management and outcomes of sepsis in Southeast Asia: a multinational multicenter prospective observational study , 2018, Journal of Intensive Care.

[16]  S. Einav,et al.  Management of invasive candidiasis and candidaemia in critically ill adults: expert opinion of the European Society of Anaesthesia Intensive Care Scientific Subcommittee. , 2017, The Journal of hospital infection.

[17]  R. Balk,et al.  The characteristics and impact of source of infection on sepsis‐related ICU outcomes , 2017, Journal of critical care.

[18]  Peter Nürnberg,et al.  Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. , 2017, The Lancet. Respiratory medicine.

[19]  I. Martín-Loeches,et al.  Pre-emptive and therapeutic value of blocking bacterial attachment to the endothelial alphaVbeta3 integrin with cilengitide in sepsis , 2017, Critical Care.

[20]  Chunsheng Li,et al.  Evaluating the value of dynamic procalcitonin and presepsin measurements for patients with severe sepsis , 2017, The American journal of emergency medicine.

[21]  E. P. Dellinger,et al.  Age and Its Impact on Outcomes with Intra-Abdominal Infection. , 2017, Surgical infections.

[22]  P. Claret,et al.  Micro-organismen en infectieziekten bij de mens: algemene principes , 2016, JAMA.

[23]  B. Souweine,et al.  Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial. , 2016, JAMA.

[24]  Derek C Angus,et al.  Toward Smarter Lumping and Smarter Splitting: Rethinking Strategies for Sepsis and Acute Respiratory Distress Syndrome Clinical Trial Design. , 2016, American journal of respiratory and critical care medicine.

[25]  M. Shankar-Hari,et al.  Evidence for a causal link between sepsis and long-term mortality: a systematic review of epidemiologic studies , 2016, Critical Care.

[26]  M. Balaan,et al.  Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.

[27]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[28]  Ran Tao,et al.  Role of Liver in Modulating the Release of Inflammatory Cytokines Involved in Lung and Multiple Organ Dysfunction in Severe Acute Pancreatitis , 2015, Cell Biochemistry and Biophysics.

[29]  Bo Liu,et al.  Role of Presepsin (sCD14-ST) and the CURB65 scoring system in predicting severity and outcome of community-acquired pneumonia in an emergency department. , 2014, Respiratory medicine.

[30]  Bo Liu,et al.  Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department , 2013, Critical Care.

[31]  Y. Imanaka,et al.  The impact of acute organ dysfunction on patients' mortality with severe sepsis , 2011, Journal of anaesthesiology, clinical pharmacology.

[32]  M. Rosner,et al.  Acute kidney injury. , 2009, Current drug targets.

[33]  David W Bates,et al.  Mortality in Emergency Department Sepsis (MEDS) score predicts 1‐year mortality* , 2007, Critical care medicine.

[34]  David W Bates,et al.  Mortality in Emergency Department Sepsis (MEDS) score: A prospectively derived and validated clinical prediction rule* , 2003, Critical care medicine.

[35]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[36]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[37]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.